Studies have shown that Genipin could significantly reduce the area of cerebral infarction and attenuate neuronal damage and necrosis by inhibiting inflammatory factors such as NLRP3, TNF-α, IL-6, and IL-1β (Zhang et al., 2021c; Zhang et al., 2021b). This evidence concerns the gene NLRP3 and cerebral infarction.